Aging and dementia are accompanied by cerebral white matter (WM) injury. which is considered to be of ischemic origin. A causal link between cerebral ischemia and WM damage has been demonstrated in rats: however. few attempts appear to have, been made to test potential drugs for the alleviation of ischemia-related WM injury. We induced cerebral hypoperfusion via permanent, bilateral occlusion of the common carotid arteries of rats. A mitochondrial ATP-sensitive potassium channel opener diazoxide (5 or its solvent dimethyl sulphoxide (DMSO) was administered i.p. (0.25 ml) on 5 consecutive. days after surgery. Sham-operated animals served as control for surgery. and non-treated rats as controls for treatments. Thirteen weeks after surgery, th...
Introduction: The pathophysiology of cerebral ischemia is essential for early diagnosis, neurologic ...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
Several clinical conditions are associated with white matter injury, including periventricular white...
Aging and dementia are accompanied by cerebral white matter (WM) injury. which is considered to be o...
Chronic cerebral hypoperfusion, a mild ischemic condition is associated with advancing age and sever...
Diazoxide has been identified as a mitochondrial, ATP-dependent K+ channel opener, and a potentially...
Diazoxide is a putative mitochondrial, ATP-sensitive potassium channel opener that has been implicat...
Background and Objective: Until now there is no drug formulated to prevent Neuronal Loss following B...
A B S T R A C T Introduction: Even today there is no effective drug therapy to prevent neuronal loss...
Though cerebral white matter injury is a frequently described phenomenon in aging and dementia, the ...
"nBackground: Dimethyl sulfoxide (DMSO) has been used as a solvent for many drugs in ischemic e...
Diazoxide (DIAZ) has been shown to be neuroprotective in animal models of different brain pathologie...
Dimethyl sulfoxide (DMSO) has a variety of biological actions that suggest efficacy as a neuroprotec...
Diazoxide, a well-known mitochondrial KATP channel opener with neuroprotective effects, has been pro...
Introduction: The pathophysiology of cerebral ischemia is essential for early diagnosis, neurologic ...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
Several clinical conditions are associated with white matter injury, including periventricular white...
Aging and dementia are accompanied by cerebral white matter (WM) injury. which is considered to be o...
Chronic cerebral hypoperfusion, a mild ischemic condition is associated with advancing age and sever...
Diazoxide has been identified as a mitochondrial, ATP-dependent K+ channel opener, and a potentially...
Diazoxide is a putative mitochondrial, ATP-sensitive potassium channel opener that has been implicat...
Background and Objective: Until now there is no drug formulated to prevent Neuronal Loss following B...
A B S T R A C T Introduction: Even today there is no effective drug therapy to prevent neuronal loss...
Though cerebral white matter injury is a frequently described phenomenon in aging and dementia, the ...
"nBackground: Dimethyl sulfoxide (DMSO) has been used as a solvent for many drugs in ischemic e...
Diazoxide (DIAZ) has been shown to be neuroprotective in animal models of different brain pathologie...
Dimethyl sulfoxide (DMSO) has a variety of biological actions that suggest efficacy as a neuroprotec...
Diazoxide, a well-known mitochondrial KATP channel opener with neuroprotective effects, has been pro...
Introduction: The pathophysiology of cerebral ischemia is essential for early diagnosis, neurologic ...
Objective: Even today there is no effective drug therapy to prevent neuronal loss after brain stroke...
Several clinical conditions are associated with white matter injury, including periventricular white...